1 – 50 of 75
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Early Blood–Brain Barrier Impairment as a Pathological Hallmark in a Novel Model of Closed-Head Concussive Brain Injury (CBI) in Mice
(
- Contribution to journal › Article
- 2023
-
Mark
Impact of simulated reduced injected dose on the assessment of amyloid PET scans
2023) In European Journal of Nuclear Medicine and Molecular Imaging(
- Contribution to journal › Article
-
Mark
From Monte Carlo PET Simulations to Reconstructed Images : Modelling and Optimisation for 68Ga Theragnostics
2023)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies
(
- Contribution to journal › Article
-
Mark
Longitudinal amyloid and tau PET imaging in Alzheimer's disease : A systematic review of methodologies and factors affecting quantification
(
- Contribution to journal › Scientific review
-
Mark
The Purification and Characterization of a Cutinase-like Enzyme with Activity on Polyethylene Terephthalate (PET) from a Newly Isolated Bacterium Stenotrophomonas maltophilia PRS8 at a Mesophilic Temperature
(
- Contribution to journal › Article
-
Mark
Discriminative accuracy of the A/T/N scheme to identify cognitive impairment due to Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
[18F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes
(
- Contribution to journal › Article
-
Mark
Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients
(
- Contribution to journal › Article
-
Mark
Brain connectomics : time for a molecular imaging perspective?
(
- Contribution to journal › Scientific review
-
Mark
Neuroimaging of Pain
2023) p.407-431(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Head-to-head comparison of relative cerebral blood flow derived from dynamic [18F]florbetapir and [18F]flortaucipir PET in subjects with subjective cognitive decline
(
- Contribution to journal › Article
- 2022
-
Mark
Quantification of amyloid PET for future clinical use : a state-of-the-art review
(
- Contribution to journal › Scientific review
-
Mark
The Importance of Dosimetry and Radiobiology in Nuclear Medicine : Quantitative methods and modelling
2022)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Alzheimer Disease : Standard of Diagnosis, Treatment, Care, and Prevention
(
- Contribution to journal › Article
-
Mark
Tau PET Imaging in Neurodegenerative Disorders
2022) In Journal of nuclear medicine : official publication, Society of Nuclear Medicine 63. p.20-26(
- Contribution to journal › Article
-
Mark
Intelligence Communities and the Media — The Case of the Danish Spymaster Lars Findsen
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Combining CRISPR-Cas9 and brain imaging to study the link from genes to molecules to networks
(
- Contribution to journal › Article
-
Mark
PSI-PSYCHO SCHIZOFRENI IMAGING : Hjärnavbildning vid Schizofreni. Del 2. Hjärnavbildning med radioaktiva spårämnen
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Does Loss of Integrity of the Cingulum Bundle Link Amyloid-β Accumulation and Neurodegeneration in Alzheimer's Disease?
(
- Contribution to journal › Article
-
Mark
Genetically identical twins show comparable tau PET load and spatial distribution
(
- Contribution to journal › Article
- 2021
-
Mark
Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts
(
- Contribution to journal › Article
-
Mark
The impact of demographic, clinical, genetic, and imaging variables on tau PET status
(
- Contribution to journal › Article
-
Mark
Artificial intelligence-based detection of lymph node metastases by PET/CT predicts prostate cancer-specific survival
(
- Contribution to journal › Article
-
Mark
Mesial temporal tau is related to worse cognitive performance and greater neocortical tau load in amyloid-β–negative cognitively normal individuals
(
- Contribution to journal › Article
-
Mark
In vivo tau pathology is associated with synaptic loss and altered synaptic function
(
- Contribution to journal › Article
-
Mark
Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects
(
- Contribution to journal › Article
-
Mark
Tau PET correlates with different Alzheimer’s disease-related features compared to CSF and plasma p-tau biomarkers
(
- Contribution to journal › Article
-
Mark
Sex differences in off-target binding using tau positron emission tomography
(
- Contribution to journal › Article
-
Mark
Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework
(
- Contribution to journal › Scientific review
-
Mark
Effect of Shortening the Scan Duration on Quantitative Accuracy of [18F]Flortaucipir Studies
(
- Contribution to journal › Article
-
Mark
Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia
(
- Contribution to journal › Article
-
Mark
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Post-reconstruction enhancement of [18F]FDG PET images with a convolutional neural network
(
- Contribution to journal › Article
-
Mark
Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Reduced repetition suppression in aging is driven by tau-related hyperactivity in medial temporal lobe
(
- Contribution to journal › Article
-
Mark
A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis
(
- Contribution to journal › Article
-
Mark
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
(
- Contribution to journal › Article
- 2020
-
Mark
Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948
(
- Contribution to journal › Article
-
Mark
Compensating for choroid plexus based off-target signal in the hippocampus using 18F-flortaucipir PET
(
- Contribution to journal › Article
-
Mark
Investigating the clinico-anatomical dissociation in the behavioral variant of Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Urbanites’ outdoor thermal comfort in the informal urban fabric of warm-humid Dar es Salaam, Tanzania
(
- Contribution to journal › Article
-
Mark
Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Imaging biomarkers in neurodegeneration : Current and future practices
(
- Contribution to journal › Scientific review
-
Mark
Recent advances of PET imaging in clinical radiation oncology
(
- Contribution to journal › Scientific review
-
Mark
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects
(
- Contribution to journal › Article
- 2019
-
Mark
Preserving Preclinical PET Quality During Intratherapeutic Imaging in Radionuclide Therapy with Rose Metal Shielding Reducing Photon Flux
(
- Contribution to journal › Article
-
Mark
18
F-fluoride as a prognostic indicator of bone regeneration
(
- Contribution to journal › Article
-
Mark
Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease
(
- Contribution to journal › Article